Page 45 - 南京医科大学自然版
P. 45
第45卷第3期 宗益平,张俊麒,王子杰,等. 广金钱草总黄酮抑制M1型巨噬细胞极化减少小鼠肾草酸钙结石形成[J].
2025年3月 南京医科大学学报(自然科学版),2025,45(3):327-333 ·333 ·
stone ⁃ free rate post ⁃ percutaneous nephrolithotomy[J]. Urolithiasis,2018,46(3):231-241
Urolithiasis,2024,52(1):64 [12]LI X,CHEN C,ZHANG T J,et al. Comparative pharmaco⁃
[5] 杨 雄,靳潇潇,何文强. 巨噬细胞在草酸钙肾结石中 kinetic studies of five C⁃glycosyl flavones in normal and
的作用研究进展[J]. 现代免疫学,2023,43(4):346⁃350 urolithiasis model rats following administration of total fla⁃
YANG X,JIN X X,HE W Q. Research progress on the vonoids from Desmodium styracifolium by liquid chroma⁃
role of macrophages in calcium oxalate kidney stones[J]. tography⁃tandem mass spectrometry[J]. J Sep Sci,2022,
Modern Immunology,2023,43(4):346-350 45(15):2901-2913
[6] 范文昌,梅全喜,赖海标. 广金钱草的药理作用和临床 [13]邓聿胤,吕纪华,王 丽,等. 广金钱草总黄酮片对大
应用研究进展[J]. 中国药房,2010,21(31):2961-2963 鼠肾结石的作用[J]. 世界中西医结合杂志,2019,14
FAN W C,MEI Q X,LAI H B. Research progress on phar⁃ (9):1252-1255
macological effects and clinical applications of Desmodi⁃ DENG Y Y,LYN J H,WANG L,et al. Efect of total flavo⁃
um stryracifolium[J]. Chinese Pharmacy,2010,21(31): noid tablets of Desmodium stryracifolium on renal calcu⁃
2961-2963 lus in rats[J]. World Journal of Integrated Traditional
[7] 刘 祺,陈 静,廖正明,等. 广金钱草总黄酮胶囊治疗 and Western Medicine,2019,14(9):1252-1255
输尿管结石(湿热蕴结证)的随机、双盲、安慰剂平行对 [14]XU Y X,LI G X,GE D F,et al. Mitochondrial dysfunction
照临床试验报告[J]. 临床泌尿外科杂志,2023,38(4): in kidney stones and relief of kidney stones after reducing
246-250 mtROS[J]. Urolithiasis,2024,52(1):117
LIU Q,CHEN J,LIAO Z M,et al. Randomized,double⁃ [15]WANG Q,WANG Y,YANG C,et al. Trends of urolithia⁃
blind,placebo paralled controlled clinical study on the sis in China:a national study based on hospitalized pa⁃
treatment of ureteral calculi with total flavonoids of Des⁃ tients from 2013 to 2018[J]. Kidney Dis,2023,9(1):49-57
modium stryracifolium[J]. Journal of Clinical Urology, [16]ZHU W,QIONG D,CHANGZHI X,et al. Macrophage po⁃
2023,38(4):246-250 larization regulation shed lights on immunotherapy for
[8] REN J F,LI J Z,FENG Y,et al. Rictor/mammalian target CaOx kidney stone disease[J]. Biomed Pharmacother,
of rapamycin complex 2 promotes macrophage activation 2024,10(179):117336
and kidney fibrosis[J]. J Pathol,2017,242(4):488-499 [17]ABUFARAJ M,XU T L,CAO C,et al. Prevalence and
[9] TAGUCHI K,OKADA A,UNNO R,et al. Macrophage trends in kidney stone among adults in the USA:analyses
function in calcium oxalate kidney stone formation:a sys⁃ of national health and nutrition examination survey 2007⁃
tematic review of literature[J]. Front Immunol,2021,12: 2018 data[J]. Eur Urol Focus,2021,7(6):1468-1475
673690 [18]鲁 佩,宋日进,张 炜,等. 优克龙对肾脏草酸钙晶体
[10]LI X,CHEN C,DING N,et al. Physiologically based phar⁃ 形成的影响及机制[J]. 南京医科大学学报(自然科学
macokinetic modelling and simulation to predict the plas⁃ 版),2021,41(11):1569-1573
ma concentration profile of schaftoside after oral adminis⁃ LU P,SONG R J,ZHANG W,et al. The effect and mecha⁃
tration of total flavonoids of Desmodium styracifolium[J]. nism of urocalum on the formation of renal calcium oxa⁃
Front Pharmacol,2022,13:1073535 late crystals[J]. Journal of Nanjing Medical University
[11]ZHOU J F,JIN J,LI X,et al. Total flavonoids of Desmodi⁃ (Natural Sciences),2021,41(11):1569-1573
um styracifolium attenuates the formation of hydroxy⁃L⁃ [收稿日期] 2024-09-16
proline ⁃ induced calcium oxalate urolithiasis in rats[J]. (本文编辑:戴王娟)

